306 related articles for article (PubMed ID: 29021240)
21. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.
Walkley CR; Qudsi R; Sankaran VG; Perry JA; Gostissa M; Roth SI; Rodda SJ; Snay E; Dunning P; Fahey FH; Alt FW; McMahon AP; Orkin SH
Genes Dev; 2008 Jun; 22(12):1662-76. PubMed ID: 18559481
[TBL] [Abstract][Full Text] [Related]
22. ONZIN Upregulation by Mutant p53 Contributes to Osteosarcoma Metastasis Through the CXCL5-MAPK Signaling Pathway.
Zhang Y; Hu Q; Li G; Li L; Liang S; Zhang Y; Liu J; Fan Z; Li L; Zhou B; Ruan Y; Yang X; Chen S; Mu T; Wang G; Xiong S
Cell Physiol Biochem; 2018; 48(3):1099-1111. PubMed ID: 30041188
[TBL] [Abstract][Full Text] [Related]
23. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
24. Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases.
Yuan J; Ossendorf C; Szatkowski JP; Bronk JT; Maran A; Yaszemski M; Bolander ME; Sarkar G; Fuchs B
Cancer Invest; 2009 May; 27(4):435-42. PubMed ID: 19212826
[TBL] [Abstract][Full Text] [Related]
25. E26 Transformation-Specific Transcription Factor ETS2 as an Oncogene Promotes the Progression of Hypopharyngeal Cancer.
Liu X; Zhang C; Zhang Z; Zhang Z; Ji W; Cao S; Cai X; Lei D; Pan X
Cancer Biother Radiopharm; 2017 Nov; 32(9):327-334. PubMed ID: 29111780
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
27. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.
Moriarity BS; Otto GM; Rahrmann EP; Rathe SK; Wolf NK; Weg MT; Manlove LA; LaRue RS; Temiz NA; Molyneux SD; Choi K; Holly KJ; Sarver AL; Scott MC; Forster CL; Modiano JF; Khanna C; Hewitt SM; Khokha R; Yang Y; Gorlick R; Dyer MA; Largaespada DA
Nat Genet; 2015 Jun; 47(6):615-24. PubMed ID: 25961939
[TBL] [Abstract][Full Text] [Related]
28. Cluster of differentiation 44 promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin.
Ma J; Klemm J; Gerardo-Ramírez M; Frappart L; Castven D; Becker D; Zoch A; Parent R; Bartosch B; Minnich K; Giovannini M; Danckwardt S; Hartmann N; Morrison H; Herrlich P; Marquardt JU; Hartmann M
Int J Cancer; 2020 Nov; 147(9):2564-2577. PubMed ID: 32525563
[TBL] [Abstract][Full Text] [Related]
29. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
Gerardo-Ramírez M; Keggenhoff FL; Giam V; Becker D; Groth M; Hartmann N; Straub BK; Morrison H; Galle PR; Marquardt JU; Herrlich P; Hartmann M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955749
[TBL] [Abstract][Full Text] [Related]
30. Mtbp haploinsufficiency in mice increases tumor metastasis.
Iwakuma T; Tochigi Y; Van Pelt CS; Caldwell LC; Terzian T; Parant JM; Chau GP; Koch JG; Eischen CM; Lozano G
Oncogene; 2008 Mar; 27(13):1813-20. PubMed ID: 17906694
[TBL] [Abstract][Full Text] [Related]
31. Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma.
Tang F; Min L; Seebacher NA; Li X; Zhou Y; Hornicek FJ; Wei Y; Tu C; Duan Z
J Orthop Res; 2019 Mar; 37(3):789-798. PubMed ID: 30667081
[TBL] [Abstract][Full Text] [Related]
32. Absence of the CD44 gene prevents sarcoma metastasis.
Weber GF; Bronson RT; Ilagan J; Cantor H; Schmits R; Mak TW
Cancer Res; 2002 Apr; 62(8):2281-6. PubMed ID: 11956084
[TBL] [Abstract][Full Text] [Related]
33. Polyoma virus-induced osteosarcomas in inbred strains of mice: host determinants of metastasis.
Velupillai P; Sung CK; Tian Y; Dahl J; Carroll J; Bronson R; Benjamin T
PLoS Pathog; 2010 Jan; 6(1):e1000733. PubMed ID: 20107604
[TBL] [Abstract][Full Text] [Related]
34. The cancer-related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis.
Villanueva F; Araya H; Briceño P; Varela N; Stevenson A; Jerez S; Tempio F; Chnaiderman J; Perez C; Villarroel M; Concha E; Khani F; Thaler R; Salazar-Onfray F; Stein GS; van Wijnen AJ; Galindo M
J Cell Physiol; 2019 Aug; 234(8):13659-13679. PubMed ID: 30637720
[TBL] [Abstract][Full Text] [Related]
35. The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.
Ahronian LG; Driscoll DR; Klimstra DS; Lewis BC
PLoS One; 2015; 10(4):e0123816. PubMed ID: 25885474
[TBL] [Abstract][Full Text] [Related]
36. MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.
Ma O; Cai WW; Zender L; Dayaram T; Shen J; Herron AJ; Lowe SW; Man TK; Lau CC; Donehower LA
Cancer Res; 2009 Mar; 69(6):2559-67. PubMed ID: 19276372
[TBL] [Abstract][Full Text] [Related]
37. Anti-cancer activity of trans-chalcone in osteosarcoma: Involvement of Sp1 and p53.
Silva G; Marins M; Fachin AL; Lee SH; Baek SJ
Mol Carcinog; 2016 Oct; 55(10):1438-48. PubMed ID: 26294168
[TBL] [Abstract][Full Text] [Related]
38. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
39. IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.
Lu J; Song G; Tang Q; Zou C; Han F; Zhao Z; Yong B; Yin J; Xu H; Xie X; Kang T; Lam Y; Yang H; Shen J; Wang J
J Clin Invest; 2015 May; 125(5):1839-56. PubMed ID: 25822025
[TBL] [Abstract][Full Text] [Related]
40. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
